161 related articles for article (PubMed ID: 20539091)
1. Relationships between markers of vascular dysfunction and neurodevelopmental outcomes in perinatally HIV-infected youth.
Kapetanovic S; Leister E; Nichols S; Miller T; Tassiopoulos K; Hazra R; Gelbard HA; Malee KM; Kammerer B; Mendez AJ; Williams PL;
AIDS; 2010 Jun; 24(10):1481-91. PubMed ID: 20539091
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers and neurodevelopment in perinatally HIV-infected or exposed youth: a structural equation model analysis.
Kapetanovic S; Griner R; Zeldow B; Nichols S; Leister E; Gelbard HA; Miller TL; Hazra R; Mendez AJ; Malee K; Kammerer B; Williams PL;
AIDS; 2014 Jan; 28(3):355-64. PubMed ID: 24670521
[TBL] [Abstract][Full Text] [Related]
3. HIV type 1 infection, and not short-term HAART, induces endothelial dysfunction.
Francisci D; Giannini S; Baldelli F; Leone M; Belfiori B; Guglielmini G; Malincarne L; Gresele P
AIDS; 2009 Mar; 23(5):589-96. PubMed ID: 19177019
[TBL] [Abstract][Full Text] [Related]
4. Neurocognitive development in HIV-positive children is correlated with plasma viral loads in early childhood.
Weber V; Radeloff D; Reimers B; Salzmann-Manrique E; Bader P; Schwabe D; Königs C
Medicine (Baltimore); 2017 Jun; 96(23):e6867. PubMed ID: 28591025
[TBL] [Abstract][Full Text] [Related]
5. Metabolic abnormalities and viral replication are associated with biomarkers of vascular dysfunction in HIV-infected children.
Miller TI; Borkowsky W; DiMeglio LA; Dooley L; Geffner ME; Hazra R; McFarland EJ; Mendez AJ; Patel K; Siberry GK; Van Dyke RB; Worrell CJ; Jacobson DL; ; Shearer W; Cooper N; Harris L; Purswani M; Baig M; Cintron A; Puga A; Navarro S; Patton D; Burchett S; Karthas N; Kammerer B; Yogev R; Malee K; Hunter S; Cagwin E; Wiznia A; Burey M; Nozyce M; Chen J; Gobs E; Grant M; Knapp K; Allison K; Garvie P; Acevedo-Flores M; Rios H; Olivera V; Silio M; Borne C; Sirois P; Spector S; Norris K; Nichols S; McFarland E; Barr E; Chambers C; Watson D; Messenger N; Belanger R; Dieudonne A; Bettica L; Adubato S; Scott G; Himic L; Willen E
HIV Med; 2012 May; 13(5):264-75. PubMed ID: 22136114
[TBL] [Abstract][Full Text] [Related]
6. HIV disease is associated with increased biomarkers of endothelial dysfunction despite viral suppression on long-term antiretroviral therapy in Botswana.
Mosepele M; Mohammed T; Mupfumi L; Moyo S; Bennett K; Lockman S; Hemphill LC; Triant VA
Cardiovasc J Afr; 2018 May/Jun 23; 29(3):155-161. PubMed ID: 29771268
[TBL] [Abstract][Full Text] [Related]
7. Biomarkers of vascular dysfunction in children infected with human immunodeficiency virus-1.
Miller TL; Somarriba G; Orav EJ; Mendez AJ; Neri D; Schaefer N; Forster L; Goldberg R; Scott GB; Lipshultz SE
J Acquir Immune Defic Syndr; 2010 Oct; 55(2):182-8. PubMed ID: 20531209
[TBL] [Abstract][Full Text] [Related]
8. Soluble markers of inflammation are associated with Framingham scores in HIV-infected patients on suppressive antiretroviral therapy.
Guzmán-Fulgencio M; Medrano J; Rallón N; Echeverria-Urabayen A; Miguel Benito J; Restrepo C; García-Álvarez M; Vispo E; San Roman J; Sánchez-Piedra C; Soriano V; Resino S
J Infect; 2011 Nov; 63(5):382-90. PubMed ID: 21855573
[TBL] [Abstract][Full Text] [Related]
9. Higher soluble CD14 levels are associated with lower visuospatial memory performance in youth with HIV.
Kim-Chang JJ; Donovan K; Loop MS; Hong S; Fischer B; Venturi G; Garvie PA; Kohn J; Rendina HJ; Woods SP; Goodenow MM; Nichols SL; Sleasman JW;
AIDS; 2019 Dec; 33(15):2363-2374. PubMed ID: 31764101
[TBL] [Abstract][Full Text] [Related]
10. Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.
Verweel G; van Rossum AM; Hartwig NG; Wolfs TF; Scherpbier HJ; de Groot R
Pediatrics; 2002 Feb; 109(2):E25. PubMed ID: 11826235
[TBL] [Abstract][Full Text] [Related]
11. Detecting epilepsy-related cognitive problems in clinically referred children with epilepsy: is the WISC-IV a useful tool?
Sherman EM; Brooks BL; Fay-McClymont TB; MacAllister WS
Epilepsia; 2012 Jun; 53(6):1060-6. PubMed ID: 22554239
[TBL] [Abstract][Full Text] [Related]
12. Early viral suppression improves neurocognitive outcomes in HIV-infected children.
Crowell CS; Huo Y; Tassiopoulos K; Malee KM; Yogev R; Hazra R; Rutstein RM; Nichols SL; Smith RA; Williams PL; Oleske J; Muller WJ;
AIDS; 2015 Jan; 29(3):295-304. PubMed ID: 25686678
[TBL] [Abstract][Full Text] [Related]
13. Monocyte activation and gut barrier dysfunction in South African youth on antiretroviral therapy and their associations with endothelial dysfunction.
Dirajlal-Fargo S; Yu J; Albar Z; Sattar A; Mahtab S; Jao J; Myer L; Zar HJ; McComsey GA
AIDS; 2020 Sep; 34(11):1615-1623. PubMed ID: 32769763
[TBL] [Abstract][Full Text] [Related]
14. The effect of initiation of antiretroviral therapy on monocyte, endothelial and platelet function in HIV-1 infection.
O'Halloran JA; Dunne E; Gurwith M; Lambert JS; Sheehan GJ; Feeney ER; Pozniak A; Reiss P; Kenny D; Mallon P
HIV Med; 2015 Nov; 16(10):608-19. PubMed ID: 26111187
[TBL] [Abstract][Full Text] [Related]
15. [HIV infection, antiretroviral therapy, and endothelium].
Hürlimann D; Weber R; Enseleit F; Lüscher TF
Herz; 2005 Sep; 30(6):472-80. PubMed ID: 16170677
[TBL] [Abstract][Full Text] [Related]
16. Human immunodeficiency virus disease severity, psychiatric symptoms, and functional outcomes in perinatally infected youth.
Nachman S; Chernoff M; Williams P; Hodge J; Heston J; Gadow KD
Arch Pediatr Adolesc Med; 2012 Jun; 166(6):528-35. PubMed ID: 22312169
[TBL] [Abstract][Full Text] [Related]
17. Peripheral biomarkers do not correlate with cognitive impairment in highly active antiretroviral therapy-treated subjects with human immunodeficiency virus type 1 infection.
Sun B; Abadjian L; Rempel H; Calosing C; Rothlind J; Pulliam L
J Neurovirol; 2010 Mar; 16(2):115-24. PubMed ID: 20307252
[TBL] [Abstract][Full Text] [Related]
18. Current update on HIV-associated vascular disease and endothelial dysfunction.
Mu H; Chai H; Lin PH; Yao Q; Chen C
World J Surg; 2007 Apr; 31(4):632-43. PubMed ID: 17372667
[TBL] [Abstract][Full Text] [Related]
19. Decrease in hospitalization and mortality rates among children with perinatally acquired HIV type 1 infection receiving highly active antiretroviral therapy.
Viani RM; Araneta MR; Deville JG; Spector SA
Clin Infect Dis; 2004 Sep; 39(5):725-31. PubMed ID: 15356789
[TBL] [Abstract][Full Text] [Related]
20. Neurocognitive dysfunction in HIV-infected youth: investigating the relationship with immune activation.
Eckard AR; Rosebush JC; O'Riordan MA; Graves CC; Alexander A; Grover AK; Lee ST; Habib JG; Ruff JH; Chahroudi A; McComsey GA
Antivir Ther; 2017; 22(8):669-680. PubMed ID: 28327462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
